Sign in

CIK 0001396814

  • Large accelerated filer

Pacira BioSciences, Inc.

Sign in to watch
Ticker
PCRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
510619477
Phone
+1 650-242-8052
Business address
2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE, CA, 94005
Former names
Pacira Pharmaceuticals, Inc., PACIRA INC, Blue Acquisition Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$217,920
in 1 filing, $218K under 10b5-1 plans

Net −$217,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. RIKER LAUREN −$218K Senior Vice President, Finance sold 9% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-06-09 REINHARDT MAX President, Rest of World Grant or award · Stock Option (Right to Buy) +17,500 17,500
2021-06-09 Reinhart Charles A. III Chief Financial Officer Grant or award +6,000 30,799
2021-06-09 Reinhart Charles A. III Chief Financial Officer Grant or award · Stock Option (Right to Buy) +15,000 15,000
2021-06-09 Riker Lauren Bullaro Vice President, Finance Grant or award +2,600 14,734
2021-06-09 Riker Lauren Bullaro Vice President, Finance Grant or award · Stock Option (Right to Buy) +6,500 6,500
2021-06-09 STACK DAVID M CEO and Chairman Grant or award +17,800 78,956
2021-06-09 STACK DAVID M CEO and Chairman Grant or award · Stock Option (Right to Buy) +133,400 133,400
2021-06-09 Williams Kristen Marie Chief Administrative Officer Grant or award +7,000 27,957
2021-06-09 Williams Kristen Marie Chief Administrative Officer Grant or award · Stock Option (Right to Buy) +17,500 17,500
2021-05-13 PACE GARY W Director Gift −1,485 128,464

Page 23 of 23 · 450 trades